Free Trial

Schrödinger (SDGR) Insider Trading & Ownership

$19.85
-0.99 (-4.75%)
(As of 09/20/2024 ET)

Schrödinger (NASDAQ:SDGR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.60%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$102,395.09
Get SDGR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Schrödinger stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SDGR Insider Buying and Selling by Quarter

Schrödinger Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/12/2024Jenny HermanSVPSell787$28.29$22,264.23  
2/12/2024Kenneth Patrick LortonCOOSell901$28.29$25,489.29  
2/12/2024Robert Lorne AbelInsiderSell1,205$27.55$33,197.75  
2/12/2024Yvonne TranEVPSell758$28.29$21,443.82  
(Data available from 1/1/2013 forward)

SDGR Insider Trading Activity - Frequently Asked Questions

The list of insiders at Schrödinger includes Jenny Herman, Karen Akinsanya, Kenneth Patrick Lorton, Nancy Thornberry, Ramy Farid, Robert Lorne Abel, and Yvonne Tran. Learn more on insiders at SDGR.

8.60% of Schrödinger stock is owned by insiders. Learn more on SDGR's insider holdings.

The following insiders have sold SDGR shares in the last 24 months: Jenny Herman ($22,264.23), Kenneth Patrick Lorton ($426,089.29), Nancy Thornberry ($519,750.00), Ramy Farid ($1,222,676.08), Robert Lorne Abel ($33,197.75), and Yvonne Tran ($941,923.42).

Insiders have sold a total of 115,387 Schrödinger shares in the last 24 months for a total of $3,165,900.77 sold.

Schrödinger Key Executives

  • Dr. Ramy Farid Ph.D. (Age 59)
    CEO, President & Director
    Compensation: $1.06M
  • Dr. Richard A. Friesner Ph.D. (Age 71)
    Co-Founder, Scientific Advisory Chairman and Director
    Compensation: $465k
  • Dr. Geoffrey Craig Porges MBBS
    Executive VP & CFO
  • Dr. Robert Lorne Abel Ph.D. (Age 42)
    Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D
    Compensation: $569.45k
  • Dr. Karen Akinsanya Ph.D. (Age 56)
    President of Research & Development Therapeutics
    Compensation: $797.74k
  • Dr. Margaret Han Dugan M.D. (Age 67)
    Chief Medical Officer
    Compensation: $707.46k
  • Prof. William Goddard III
    Co-Founder & Scientific Advisor
  • Mr. Kenneth Patrick Lorton (Age 40)
    Executive VP, CTO & COO of Software
    Compensation: $510.09k
  • Mr. Shane Brauner (Age 46)
    Executive VP & Chief Information Officer
  • Ms. Jaren Irene Madden
    Senior Vice President of Investor Relations & Corporate Communications


This page (NASDAQ:SDGR) was last updated on 9/22/2024 by MarketBeat.com Staff
From Our Partners